Cleared Traditional

K110381 - CELL-DYN EMERALD 22 SYSTEM

K110381 is an FDA 510(k) clearance for CELL-DYN EMERALD 22 SYSTEM, manufactured by Abbott Laboratories. The device is a Class 2 Hematology device with product code GKZ cleared through the Traditional 510(k) pathway after a 315-day FDA review.

K110381 · Abbott Laboratories · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2011
Decision
315d
Days
Class 2
Risk

K110381 is an FDA 510(k) clearance for the CELL-DYN EMERALD 22 SYSTEM. Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Abbott Laboratories (Santa Clara, US). The FDA issued a Cleared decision on December 22, 2011 after a review of 315 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K110381

510(k) Number K110381 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 10, 2011
Decision Date December 22, 2011
Days to Decision 315 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
202d slower than avg
Panel avg: 113d · This submission: 315d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GKZ Device Classification - Class 2, Special Controls

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 226
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K110381.
UNICEL DXH 800 COULTER CELLULAR ANALYSIS SYSTEM/ UNICEL DXH SLIDEMAKER STAINER COULTER CELLULAR ANALYSIS SYSTEM
K140911 · Beckman Coulter, Inc. · Sep 2014
UNICEL DXH 800 COULTER CELLULAR ANALYSIS SYSTEM
K120771 · Beckman Coulter, Inc. · Mar 2013
SYSMEX XN-SERIES
K112605 · Sysmex America, Inc. · Oct 2012
ADVIA 2120 WITH AUTOSLIDE SYSTEM, AND ADVIA 2120I
K102644 · Siemens Healthcare Diagnostics · Nov 2011
BD FACS SAMPLE PREP ASSISTANT III (SPA III)
K102064 · Becton, Dickinson & CO · Mar 2011
ADVIA 2120/2120I BODY FLUIDS
K090346 · Siemens Healthcare Diagnostics · Jul 2010